Follow
Thierry Kogej
Thierry Kogej
Associate Principal Scientist, AstraZeneca
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
Design of organic molecules with large two-photon absorption cross sections
M Albota, D Beljonne, JL Brédas, JE Ehrlich, JY Fu, AA Heikal, SE Hess, ...
Science 281 (5383), 1653-1656, 1998
27471998
Generating focused molecule libraries for drug discovery with recurrent neural networks
MHS Segler, T Kogej, C Tyrchan, MP Waller
ACS central science 4 (1), 120-131, 2017
14292017
Mechanisms for enhancement of two-photon absorption in donor–acceptor conjugated chromophores
T Kogej, D Beljonne, F Meyers, JW Perry, SR Marder, JL Brédas
Chemical Physics Letters 298 (1-3), 1-6, 1998
4071998
Designing novel building blocks is an overlooked strategy to improve compound quality
FW Goldberg, JG Kettle, T Kogej, MWD Perry, NP Tomkinson
Drug Discovery Today 20 (1), 11-17, 2015
2082015
Tuning the two-photon absorption response of quadrupolar organic molecules
E Zojer, D Beljonne, T Kogej, H Vogel, SR Marder, JW Perry, JL Bredas
The Journal of chemical physics 116 (9), 3646-3658, 2002
1502002
Datasets and their influence on the development of computer assisted synthesis planning tools in the pharmaceutical domain
A Thakkar, T Kogej, JL Reymond, O Engkvist, EJ Bjerrum
Chemical science 11 (1), 154-168, 2020
1262020
Straightforward strategies for the preparation of NH-sulfoximines: a serendipitous story
JA Bull, L Degennaro, R Luisi
Synlett 28 (19), 2525-2538, 2017
1222017
ChemGPS-NPWeb: chemical space navigation online
J Rosén, A Lövgren, T Kogej, S Muresan, J Gottfries, A Backlund
Journal of computer-aided molecular design 23, 253-259, 2009
1182009
Secondary metabolites from cetrarioid lichens: Chemotaxonomy, biological activities and pharmaceutical potential
M Xu, S Heidmarsson, ES Olafsdottir, R Buonfiglio, T Kogej, S Omarsdottir
Phytomedicine 23 (5), 441-459, 2016
952016
Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data
S Muresan, P Petrov, C Southan, MJ Kjellberg, T Kogej, C Tyrchan, ...
Drug Discovery Today 16 (23-24), 1019-1030, 2011
942011
Multifingerprint based similarity searches for targeted class compound selection
T Kogej, O Engkvist, N Blomberg, S Muresan
Journal of chemical information and modeling 46 (3), 1201-1213, 2006
842006
Big pharma screening collections: more of the same or unique libraries? The AstraZeneca–Bayer Pharma AG case
T Kogej, N Blomberg, PJ Greasley, S Mundt, MJ Vainio, J Schamberger, ...
Drug discovery today 18 (19-20), 1014-1024, 2013
802013
Comparison of molecular fingerprint methods on the basis of biological profile data
A Steffen, T Kogej, C Tyrchan, O Engkvist
Journal of chemical information and modeling 49 (2), 338-347, 2009
692009
LibINVENT: Reaction-based Generative Scaffold Decoration for in Silico Library Design
V Fialková, J Zhao, K Papadopoulos, O Engkvist, EJ Bjerrum, T Kogej, ...
Journal of Chemical Information and Modeling 62 (9), 2046-2063, 2021
532021
Cheminformatics in drug discovery, an industrial perspective
H Chen, T Kogej, O Engkvist
Molecular Informatics 37 (9-10), 1800041, 2018
532018
Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists
C Pégurier, P Collart, P Danhaive, S Defays, M Gillard, F Gilson, T Kogej, ...
Bioorganic & medicinal chemistry letters 17 (15), 4228-4231, 2007
522007
Applications of deep-learning in exploiting large-scale and heterogeneous compound data in industrial pharmaceutical research
L David, J Arús-Pous, J Karlsson, O Engkvist, EJ Bjerrum, T Kogej, ...
Frontiers in pharmacology 10, 1303, 2019
492019
AI-assisted synthesis prediction
S Johansson, A Thakkar, T Kogej, E Bjerrum, S Genheden, T Bastys, ...
Drug Discovery Today: Technologies 32, 65-72, 2019
472019
Dual NK1 antagonists—serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives
T Ryckmans, O Berton, R Grimée, T Kogej, Y Lamberty, P Pasau, ...
Bioorganic & medicinal chemistry letters 12 (21), 3195-3198, 2002
432002
Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds
C Tyrchan, N Blomberg, O Engkvist, T Kogej, S Muresan
Bioorganic & medicinal chemistry letters 19 (24), 6943-6947, 2009
422009
The system can't perform the operation now. Try again later.
Articles 1–20